Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (2091)	2/24/2002 1:25:56 PM
From: Cacaito	Respond to of 2515

..."that the ONLY way BMY will get value out of the deal" Well, assuming the best possible outcome: drug is effective, approvable and billion dollar potential in a short period (less than a year), YES. But the drug is so far a failure. Non approvable. Even if approvable, already delay minimun one year from expectation. And the billion $ potential is also in doubt. wacksals also sold another $45M in jan 18, the rest of Imcl Executives (all the insiders, including some institutions that tender preferentially like mutual funds, insures, banks, venturers) all of them are the major balk of the $1B in stock sold to Bmy, so IF, IF, IF insider trading is confirmed there is a LOT of money to get back to the company and therefore easier for Bmy to get money back. Are Bmy behavior and demands the usual for big pharma/biotech relations that "ONLY" a rosy possibility for resolution of conflict is the way to go? Why did MerckKag PUBLICLY and OFFICIALLY claim that they knew NOTHING about the FDA situation until it was pr by imcl? BECAUSE Mercky does not want to give the minimal impression of insider trading and that way protect about $120 millions they got selling imclone shares. "short March puts at 20", Sorry, I do not understand, did you buy puts? or did you sell puts?